Feedback / Questions
SL-172154 - Shattuck
https://www.globenewswire.com/news-release/2024/06/10/2895899/0/en/Shattuck-Labs-Announces-Orphan-Drug-Designation-Granted-by-the-U-S-Food-and-Drug-Administration-FDA-for-SL-172154-for-the-Treatment-of-Acute-Myeloid-Leukemia-AML.html
Jun 10, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next